Product
Control Rx
6 clinical trials
11 indications
Indication
Congestive Heart FailureIndication
HIV InfectionsIndication
Refractory Angina PectorisIndication
Vitamin CIndication
Postoperative PainIndication
Gene TransferIndication
Coronary Artery DiseaseIndication
Nonalcoholic Fatty Liver DiseaseIndication
Hepatic SteatosisIndication
Colorectal CancerClinical trial
Polypill Strategy for the Evidence-Based Management of Heart Failure With Reduced Ejection Fraction in an Underserved Patient PopulationStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Developing a Heart Failure Polypill to Improve Outcomes at a Safety Net Hospital: A Pilot Crossover Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Clinical Development and Proof of Principle Testing of New Regenerative Adenovirus Vascular Endothelial Growth Factor (VEGF-D) Therapy for Cost-effective Treatment of Refractory Angina. A Phase II Randomized, Double-blinded, Placebo-controlled Study (ReGenHeart)Status: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
The Impact of Intravenous Vitamin C Combined With Nerve Blocks on Postoperative Pain and Recovery After Total Knee Arthroplasty.Status: Completed, Estimated PCD: 2023-12-07
Clinical trial
Effect of Dulaglutide vs Empagliflozin on Non-alcoholic Fatty Liver Disease of Patients With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2021-05-31
Clinical trial
Chidamide+Sintilimab+Bevacizumab Versus Standard Second-Line Therapy of FOLFIRI+Bevacizumab in Subjects With Advanced Microsatellite Stable (MSS/pMMR) Colorectal Cancer Who Have Failed Oxaliplatin-Containing First-Line TherapyStatus: Recruiting, Estimated PCD: 2026-01-01